Shares of Mead Johnson Nutrition Company (MJN) Sees Large Inflow of Net Money Flow

Mead Johnson Nutrition Company (MJN) stock had a bullish inflow of $1.13 million worth of trades on uptick and an outflow of $0.15 million in downticks on Friday. The total uptick to downtick ratio stood at 7.32. The net money flow into the stock was $0.98 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $0.98 million. $0.98 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. However, Mead Johnson Nutrition Company (MJN) stock traded down $0.05 , and reached $91.19, a drop of -0.05% over the previous day. On a weekly basis, the stock is -0.21%, over the previous weeks close.


Mead Johnson Nutrition Company (MJN) : The highest level Mead Johnson Nutrition Company (MJN) is projected to reach is $91 for the short term and the lowest estimate is at $75. The consolidated price target from 6 rating analysts who initiate coverage on the stock is $84.17 and the possibility the share price can swing is $5.6.

Mead Johnson Nutrition Company (NYSE:MJN): stock turned positive on Friday. Though the stock opened at $91.5, the bulls momentum made the stock top out at $92.02 level for the day. The stock recorded a low of $90.866 and closed the trading day at $91.86, in the green by 0.68%. The total traded volume for the day was 1,327,607. The stock had closed at $91.24 in the previous days trading.

In a related news, The Securities and Exchange Commission has divulged that Stratton Christoper Richard, officer (SVP and President, Asia) of Mead Johnson Nutrition Co, had unloaded 33,730 shares at an average price of $86.68 in a transaction dated on May 2, 2016. The total value of the transaction was worth $2,923,716.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.